Navigation Links
AASLD President's Choice Lecture: The National Strategy for the Control of Viral Hepatitis and Liver Cancer
Date:11/1/2010

BOSTON, Nov. 1, 2010 /PRNewswire/ -- Dr. Howard Koh, the 14th Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS), described the steps the U.S. administration is taking in response to the recent Institute of Medicine (IOM) report on viral hepatitis in his 2010 President's Choice Lecture at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (AASLD). Dr. Koh formed and led a U.S. Department of Health and Human Services-wide team that will soon issue a hepatitis action plan that will leverage new funding opportunities and integrate activities throughout HHS to build true systems of care for high-risk individuals.

Additionally, the plan will be used to strengthen partnerships with federal, professional, and patient organizations in an effort to set and implement policies to guide public health and clinical practice. Other goals of the plan will be to harmonize screening guidelines, create new strategies for workforce development, and improve hepatitis B vaccination rates for adults at high risk. Dr. Koh stressed the need for collaboration in addressing the epidemic of hepatitis, including the need to work with state and local health leaders and create stronger links with professional societies such as AASLD. The report will address the need for prevention and building the capacity for reducing the number and incidence of viral hepatitis infections and improving the health of patients and economic consequences of viral hepatitis.

Dr. Koh also praised the recent Trust for America's Health report developed in collaboration with AASLD that translates the IOM report into language that may be used to affect appropriations to support research and health care delivery for liver disease and also to be used in future legislation to make the screening, early detection, and treatment of viral hepatitis a reality.

Viral hepatitis is the fourth leading infectious
'/>"/>

SOURCE American Association for the Study of Liver Diseases
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
2. Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C
3. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
4. Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
5. Pharmasset to Webcast an Investor Event from the AASLD Meeting
6. ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
7. Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD
8. Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women
9. Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus
10. IncentOne Introduces Next Generation of Healthy Choice Award(TM) Incentive Solution to Drive Consumer and Provider Engagement
11. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 STAAR Surgical Company ... and marketer of minimally invasive ophthalmic products, today announced ... to review the Company,s recent financial results and business ... Surgical will present at the 38 th Annual ... at the Westin Waterfront Hotel on Wednesday, ...
(Date:5/20/2013)... 2013  Volcano Corporation (NASDAQ: VOLC ) ... tools designed to enhance the diagnosis and treatment of ... highlight its efforts to expand research and innovation surrounding ... and iFR ® (Instant Wave-Free Ratio™) 1 ... at EuroPCR 2013 in Paris . ...
(Date:5/20/2013)... May 20, 2013 The Board of ... companies include OMNIlife science®, Inc., Enztec, Ltd., and Praxim, ... Board.  Guy Mayer , an ... of the Board of Directors and David Johnson, an ... director. Before joining OSI as Board ...
Breaking Medicine Technology:STAAR Surgical To Present At Upcoming Investor Conferences 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3
... The Female Health Company (NASDAQ-CM: FHCO) today announced ... Comercio (Semina), was successful in a public tender to ... to 20 million FC2 Female Condoms.  The contract is ... will be determined at the Ministry of Health,s discretion. ...
... 6, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Financial Officer, August J. Moretti will present during the MDB ... Tuesday, May 10, 2011 at 10:00 a.m. Eastern Time.  The ... To access the presentation via the Web, please go ...
Cached Medicine Technology:The Female Health Company's Brazilian Distributor, Semina, Awarded Contract For Up To 20 Million FC2 Female Condoms 2The Female Health Company's Brazilian Distributor, Semina, Awarded Contract For Up To 20 Million FC2 Female Condoms 3Alexza to Present at the MDB Bright Lights Conference 2011 2Alexza to Present at the MDB Bright Lights Conference 2011 3
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... but some of the changes brought about by the ... New research has found that people with diabetes ... higher risk of having a severe low blood sugar ... to people with diabetes who aren,t depressed. ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... The team at Comfort &Harmony™, a leader in nurturing baby ... nursing pillow. , Nursing pillows are designed for ... , In a nursing pillow, important things to look ... at Comfort & Harmony, kept this list in mind when ... needs to fit a mom’s body and feel comfortable. Some ...
(Date:5/21/2013)... May 21, 2013 Vyopta Incorporated, ... automation applications for video collaboration, today announced the ... index evaluates key performance metrics related to quality, ... immediate, aggregated indicator of the performance of their ... Vyopta vAnalytics™ application, the vRating™ delivers high level ...
(Date:5/21/2013)... Ohio universities and four hospitals have joined with the ... research program aimed exclusively at finding the unknown causes ... invest $10 million in the program over five years. ... -- Ohio Collaborative is a unique research enterprise," says ... Dimes. "This new transdisciplinary, team-based research model will leverage ...
Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3
... getting the medications they need, researchers say , , MONDAY, ... American children have attention-deficit/hyperactivity disorder (ADHD), but only 32 ... , That,s the sobering conclusion of a landmark new ... doctors consider the "gold standard" of diagnostic criteria -- ...
... Stock in the SDAX as Per September 6, 2007 ... Outside the Normal Schedule, ... September, DÜSSELDORF, Germany, September 3 Gerresheimer AG has,been listed in ... one of the largest IPOs of the year, with a total,issue volume ...
... Belgium, September 3 KFH has announced that ... ISO 13485 and ISO,9001:2000 quality management systems with ... Dr Sally Sennitt, MD, says: "We are delighted,to ... systems,through working with BSI. It is a major ...
... year-round consumption of fresh leafy greens such as lettuce ... produce free from contamination by food poisoning bacteria, according ... at the Society for General Microbiologys 161st Meeting at ... September 2007. , The only land suitable for supplying ...
... treatment of schizophrenia, INDIANAPOLIS, Sept. 2 An ... Medicine,demonstrates that for the first time in humans a ... mGlu2/3 has antipsychotic activity. The study,was sponsored by Eli ... this study - a randomized, double-blind, placebo-controlled clinical,trial - ...
... buzzing with electrical activity created by sodium and potassium ... pores. To prevent the constant chatter from descending into ... be tightly regulated. , One possibility is to ... dumpster, discovered researchers at the Salk Institute for Biological ...
Cached Medicine News:Health News:9% of U.S. Kids Have ADHD 2Health News:9% of U.S. Kids Have ADHD 3Health News:Lettuce, leafy greens and E. coli 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 3Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 4Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 5Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 6Health News:A drug-sensitive 'traffic cop' tells potassium channels to get lost 2
... Room Knee Brace frees the ... the time-consuming post-op fitting and ... more complex brace designs. The ... provides the same benefits as ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
SofTec Genu is the first functional brace that provides full soft tissue control, enhances natural muscle movement, prevents atrophy, increases proprioception and controls A/P laxity....
Medicine Products: